Review links genetic variation with anticoagulant handling and clinical events
A review combined published studies and statistical modelling to explore genetic associations with anticoagulant processing, bleeding and stroke in people with atrial fibrillation.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The authors report associations between genetic variation, how the body handles oral anticoagulants, and bleeding or stroke outcomes, especially for dabigatran and apixaban. However, the abstract does not establish that choosing treatment through genetic testing improves patient outcomes. Its reported risk thresholds lack enough context to give readers a dependable estimate of personal risk.
This abstract-based explanation cannot assess the underlying studies or model validation. The abstract does not specify reference groups, follow-up periods or how its risk thresholds were derived, limiting interpretation of the reported clinical risks.
What the analysis examined
The researchers examined genetic variants in relation to drug handling and clinical events. They combined a systematic review with statistical models, simulations and grouping analyses to explore relationships among the variables.
What the authors reported
The abstract describes genetic links with dabigatran metabolism, apixaban safety, rivaroxaban effectiveness and edoxaban clearance. Its conclusion particularly highlights associations between blood drug concentrations and bleeding or stroke risks for dabigatran and apixaban.
The original publication
Structural equation modelling of nucleotide polymorphisms and pharmacokinetics in direct oral anticoagulant use for stroke and embolism prevention in atrial fibrillation.
Pham TP, Pham HT, Doan PM et al.
Eur J Pharmacol · 2025
- PubMed ID
- 40783160
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.